PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PPBT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/25

04:20 pm

ppbt

Purple Biotech Announces Plan to Implement ADS Ratio Change

Medium Report

Purple Biotech Announces Plan to Implement ADS Ratio Change

Report

1/7

08:00 am

ppbt

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

Low Report

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

Report

12/30

04:14 pm

ppbt

Purple Biotech (NASDAQ:PPBT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Purple Biotech (NASDAQ:PPBT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

12/11

07:00 am

ppbt

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

High Report

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.